August 19, 2008


Monsanto to sell BST hormone business to concentrate on seeds


Seed-maker Monsanto has announced it will sell its POSILAC bovine somatotropin (BST) business.


BST is used to boost milk yields in the USA, but is banned in the EU on human health grounds.


The company said the sale would help it concentrate on the profitable GM crop sector and crop protection products.


Calling POSILAC a strong product, Carl Casale, Monsanto's executive vice-president of strategy and operations said repositioning the business will allow Monsanto to focus on the growth of its core seeds and traits business while ensuring that loyal dairy farmers continue to receive the value of POSILAC in their operations.

Video >

Follow Us